title: Evaluation of a gene expression microarray-based assay to determine tissue type of origin on a diverse set of 49 malignancies.
abstract: The Tissue of Origin Frozen (TOO-FRZ) assay from Pathwork Diagnostics has been cleared by the Food and Drug Administration as a diagnostic study for malignancies of unknown primary. The goal of this study was to evaluate the performance of TOO-FRZ on a diverse collection of malignancies. We collected a diverse set of 49 malignancies. We classified each case into 1 of 4 groups: common morphology from a tissue type included in the TOO-FRZ assay (n=29), uncommon morphology from a tissue type included in the TOO-FRZ assay (n=10), tumor from a tissue type not included in the TOO-FRZ assay (n=3), and malignancies of unknown primary (n=7). We found strong diagnostic performance for common morphologies from tissue types on the TOO-FRZ [overall accuracy=26 of 29 (90%, 95% CI, 73% to 97%)], with perfect performance in all tissue types except gastric (0 of 2) and pancreatic (1 of 2) tissues. There was a significant decline in performance for uncommon morphologies from tissue types included in the TOO-FRZ assay [6 of 10 (60%) cases with an indeterminate result, 1 of 10 (10%) cases with an incorrect prediction, and 3 of 10 (30%) with a correct prediction] and for tumors from tissue types not included in the assay (incorrect prediction in 2 of 3 cases). For the 7 malignancies of unknown primary in our study set, the TOO-FRZ provided a likely clinically useful result in only 2 of 7 cases. These results provide an insight into the strengths and limitations of this molecular assay for the surgical pathologist, and our findings suggest future directions for research in this area.
authors: Department of Pathology, Stanford University School of Medicine, CA, USA.
authors: Andrew H
authors: AH
authors: Beck
authors: Juan
authors: J
authors: Rodriguez-Paris
authors: James
authors: J
authors: Zehnder
authors: Iris
authors: I
authors: Schrijver
references: Br J Cancer. 2003 Aug;89 Suppl 1:S59-66
references: 12915904
references: J Mol Diagn. 2011 Jan;13(1):48-56
references: 21227394
references: Int J Cancer. 2009 Sep 15;125(6):1390-7
references: 19536816
references: Diagn Pathol. 2010 Apr 26;5:26
references: 20420692
references: Histopathology. 2010 Feb;56(3):277-85
references: 20459528
references: J Mol Diagn. 2008 Jan;10(1):67-77
references: 18083688
references: J Clin Oncol. 2008 Sep 20;26(27):4435-41
references: 18802156
references: J Clin Oncol. 2009 May 20;27(15):2503-8
references: 19332734
references: Am J Surg Pathol. 2005 May;29(5):660-5
references: 15832091
references: Br J Cancer. 2008 Apr 22;98(8):1425-30
references: 18414470
references: Anal Cell Pathol. 1995 Dec;9(4):311-23
references: 8616106
references: J Clin Oncol. 2008 Sep 20;26(27):4442-8
references: 18802157
references: Eur J Cancer. 2007 Sep;43(14):2026-36
references: 17698346
references: Semin Diagn Pathol. 2000 Aug;17(3):184-93
references: 10968704
references: Cancer Res. 2005 May 15;65(10):4031-40
references: 15899792
references: Diagn Pathol. 2010 Jan 13;5:3
references: 20205775